NECFA
SGTX

New England Capital Financial Advisors’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

New England Capital Financial Advisors’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3
Closed -$38 – 448
2023
Q1 		$38 Hold
3
– – ﹤0.01% 430
2022
Q4 		$30 Buy
+3
New +$30 ﹤0.01% 437